In this issue of Hematology/Oncology Clinics, guest editors Drs. Alex F. Herrera and Alison J. Moskowitz bring their considerable expertise to the topic of New Developments in Hodgkin's Lymphoma. Top experts focus on how advances in our understanding of Hodgkin’s lymphoma biology, diagnostics, and novel therapies have revolutionized the management of Hodgkin’s lymphoma.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime? - p. 165 9. Early-Stage Hodgkin Lymphoma: Time for Novel Agents? - p. 179 10. New Standards in Advanced-stage Hodgkin Lymphoma: Selecting a Novel Regimen - p. 199 11. Classic Hodgkin Lymphoma in the Older Adult: What’s New? - p. 213 12. Management of Classic Hodgkin Lymphoma in Pregnancy - p. 231 13. New Developments in Hodgkin's Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma - p. 247 14. The Modern Role of Radiation Therapy in Classic Hodgkin Lymphoma - p. 257 15. Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies - p. 275 16. The Role of Stem Cell Transplantation in Hodgkin Lymphoma - p. 289 17. Cellular and Novel Immunotherapies for Classic Hodgkin Lymphoma - p. 303
In this issue of Hematology/Oncology Clinics, guest editors Drs. Alex F. Herrera and Alison J. Moskowitz bring their considerable expertise to the topic of New Developments in Hodgkin's Lymphoma. Top experts focus on how advances in our understanding of Hodgkin’s lymphoma biology, diagnostics, and novel therapies have revolutionized the management of Hodgkin’s lymphoma.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime? - p. 165 9. Early-Stage Hodgkin Lymphoma: Time for Novel Agents? - p. 179 10. New Standards in Advanced-stage Hodgkin Lymphoma: Selecting a Novel Regimen - p. 199 11. Classic Hodgkin Lymphoma in the Older Adult: What’s New? - p. 213 12. Management of Classic Hodgkin Lymphoma in Pregnancy - p. 231 13. New Developments in Hodgkin's Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma - p. 247 14. The Modern Role of Radiation Therapy in Classic Hodgkin Lymphoma - p. 257 15. Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies - p. 275 16. The Role of Stem Cell Transplantation in Hodgkin Lymphoma - p. 289 17. Cellular and Novel Immunotherapies for Classic Hodgkin Lymphoma - p. 303
